The cost and preparation of clinical trials involving human subjects are hurdles that must be overcome by private stem cell research companies in the pre-clinical stage. Because of these associated difficulties, researchers attempt to learn what they can from animal trials, including real-world veterinary stem cell cures for large animals.
Stem cell research has resulted in therapeutic applications that are working on dogs and horses in particular. In a post we'll be doing in the near future we'll talk about two private stem cell companies, one specializing in adipose (fat) stem cells, the other in bone marrow, that have made a significant impact on the world of veterinary medicine. A lot of knowledgeable stem cell stake holders will be watching the latest UC Davis investment in the future of large animal veterinary medicine. So, exactly what is UC Davis doing?